Who’s to blame for high drug prices? Most would probably point the finger at Big Pharma, but a group representing pharmacists say that a big part of the problem is middlemen empowered by insurance companies.
“Direct and indirect remuneration fees imposed on community pharmacies and increased costs for patients at the pharmacy counter through copay clawback fees” are the two main issues driving up the cost of meds at neighborhood drug stores, says a report from the Alexandria, Virginia-based National Community Pharmacists Association.
Both problems, says the group, are driven by pharmacy benefit management companies. Such companies are increasingly hired by health insurers to oversee their prescription drug benefits.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
